Position in GH
as of Jun 30, 2026
· filed Aug 5, 2026
Position Value
$54,614,220
-$23,153,653 QoQ
Shares Held
364,022
-56.8% QoQ
Ownership
0.271%
of shares outstanding
% of Portfolio
1.29%
of 13F equity value
Holder Rank
#67
of 593 holders
Holding Since
Mar 2025
6 quarters on record
Voting authority
Sole 76%
Shared 0%
None 24%
Common Shares in GH Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026EMERALD ADVISERS, LLC holds $122,557,718 across 3 Diagnostics & Research names. GH ranks #1 (44.6% of the industry book) .
All Filings in GH
Export CSV
6 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $54,614,220 | 364,022 | Shares | Sole | 2026-08-05 | |
| 2026-03-31 | $77,767,873 | 841,917 | Shares | Sole | 2026-05-04 | |
| 2025-12-31 | $88,026,703 | 861,824 | Shares | Sole | 2026-02-09 | |
| 2025-09-30 | $54,557,723 | 873,203 | Shares | Sole | 2025-10-30 | |
| 2025-06-30 | $36,423,940 | 699,922 | Shares | Sole | 2025-08-04 | |
| 2025-03-31 | $22,638,662 | 531,424 | Shares | Sole | 2025-05-01 | |
| No filing history on record for this holder in this stock. | ||||||